Publications by authors named "Yuko Tanibuchi"

Claim this Profile
C
Clinical characteristics of over-the-counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers.
Yuko Tanibuchi, Soichiro Omiya, Takashi Usami, Toshihiko Matsumoto

Neuropsychopharmacol Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.
Hiroko Kotajima-Murakami, Ayumi Takano, Shinya Hirakawa, Yasukazu Ogai, Daisuke Funada, Yuko Tanibuchi

Neuropsychopharmacol Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders.
Toshihiko Matsumoto, Toshitaka Kawabata, Kyoji Okita, Yuko Tanibuchi, Daisuke Funada

Neuropsychopharmacol Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
Hiroko Kotajima-Murakami, Ayumi Takano, Yasukazu Ogai, Shotaro Tsukamoto, Maki Murakami, Yuko Tanibuchi

Neuropsychopharmacol Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of clinical symptoms in patients with new psychoactive substance (NPS)-related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction.
Daisuke Funada, Toshihiko Matsumoto, Yuko Tanibuchi, Yasunari Kawasoe, Satoru Sakakibara

Neuropsychopharmacol Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
Yuko Tanibuchi, Toshihiko Matsumoto, Daisuke Funada, Takuya Shimane

Neuropsychopharmacol Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014.
Toshihiko Matsumoto, Hisateru Tachimori, Ayumi Takano, Yuko Tanibuchi, Daisuke Funada

Psychiatry Clin Neurosci· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP): for patients with drug use disorder: A study on factors influencing 1-year follow-up outcomes].
Yuko Tanibuchi, Toshihiko Matsumoto, Fumi Imamura, Asako Wakabayashi, Hiraku Kawachi

Nihon Arukoru Yakubutsu Igakkai Zasshi· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Response to treatment of patients abusing the "dappou drug" who participated in a group relapse prevention program: a comparison with patients abusing methamphetamine].
Emi Hikitsuchi, Toshihiko Matsumoto, Kiyoshi Wada, Yuko Tanibuchi, Ayumi Takano

Nihon Arukoru Yakubutsu Igakkai Zasshi· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of patients with designer-drug-related disorder in Japan: a comparison with patients with methamphetamine- and hypnotic/anxiolytic-related disorders.
Toshihiko Matsumoto, Hisateru Tachimori, Yuko Tanibuchi, Ayumi Takano, Kiyoshi Wada

Psychiatry Clin Neurosci· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
Yuko Tanibuchi, Toshihiko Matsumoto, Ohji Kobayashi, Kiyoshi Wada

Seishin Shinkeigaku Zasshi· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of methamphetamine use disorder treated with the antibiotic drug minocycline.
Yuko Tanibuchi, Minoru Shimagami, Goro Fukami, Yoshimoto Sekine, Masaomi Iyo

Gen Hosp Psychiatry· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recent findings about biomarkers in the peripheral blood of drug abusers: mainly about BDNF and cytokine].
Yuko Tanibuchi, Masaomi Iyo, Kenji Hashimoto

Nihon Arukoru Yakubutsu Igakkai Zasshi· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.
Jin Wu, Jun Toyohara, Yuko Tanibuchi, Yuko Fujita, Jichun Zhang

Brain Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
Yuko Tanibuchi, Jin Wu, Jun Toyohara, Yuko Fujita, Masaomi Iyo

Brain Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
Yuko Tanibuchi, Yuko Fujita, Mami Kohno, Tamaki Ishima, Yuto Takatsu

Eur Neuropsychopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
Shinsui Kunitachi, Yuko Fujita, Tamaki Ishima, Mami Kohno, Mao Horio, Yuko Tanibuchi

Brain Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis